CAMBRIDGE, Mass.--(BUSINESS WIRE)--Warp Drive Bio, a biotechnology company using the molecules and mechanisms of nature to discover and develop transformative medicines, today announced that Laurence Reid, chief executive officer, will present a corporate overview at the Cowen and Company 36th Annual Healthcare Conference on Tuesday, March 8, 2016 at 4 p.m. ET in the MIT Room at the Marriott Copley Place in Boston.
About Warp Drive Bio
Warp Drive Bio is exploiting the molecules and mechanisms of nature to create transformative medicines. The company operates on the core principle that nature is the world’s most powerful inventor of new drugs, unconstrained by the mechanistic and synthetic limitations of traditional medicinal chemistry. Warp Drive Bio is deploying its proprietary Genomic Mining and SMARTTM (Small Molecule Assisted Receptor Targeting) platforms, to discover novel medicines that have the potential to make a significant difference in patients’ lives. The company was launched in 2012 through a strategic partnership with Sanofi and with financing from Third Rock Ventures and Greylock Partners. For more information, please visit www.warpdrivebio.com.
